Circulating Non-coding RNAs as Potential Biomarkers for Ischemic Stroke: A Systematic Review
Related Experiment Video
Updated: Sep 28, 2025
Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Jingjing Zhao1, Qianwen Wang1, Ruixia Zhu2
1Department of Neurology, The First Affiliated Hospital of China Medical University, Shenyang, 110001, China.
Background:
Recent studies have demonstrated that dysregulated non-coding RNAs (ncRNAs) are involved in the pathogenesis of ischemic stroke (IS), including neuroinflammation, apoptosis, atherosclerosis, and angiogenesis. However, discrepant results make it difficult to apply ncRNAs to clinical practice. Therefore, we performed a meta-analysis to evaluate and elucidate the diagnostic value of ncRNAs in IS.
Methods:
We searched the literature in four databases-PubMed, Web of Science, EMBASE, and the Cochrane Library-up to December 31, 2020, to identify the relationship between differentially expressed ncRNAs and IS. Pooled sensitivity and specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and the corresponding 95% confidence intervals (95% CIs) were calculated to assess the diagnostic performance of ncRNAs.
Results:
Fifteen studies on microRNAs (miRNAs) including 1687 IS patients and eight studies on long non-coding RNAs (lncRNAs) including 741 IS patients were included in our study. Estimates of the identification efficiency of miRNAs from the 15 studies were as follows: 0.76 (95% CI: 0.67-0.84) for sensitivity (SEN), 0.83 (95% CI: 0.77-0.88) for specificity (SPE), 4.5 (95% CI: 3.4-6.1) for PLR, 0.29 (95% CI: 0.20-0.40) for NLR, and 16 (95% CI: 10-26) for DOR. The area under the curve (AUC) of the summary receiver operator characteristic (SROC) curve showed diagnostic accuracy of 0.87 (95% CI: 0.84-0.90); thus the diagnostic value of all the miRNAs was moderate. In addition, the results for lncRNAs were as follows: 0.73 (95% CI: 0.69-0.77) for SEN, 0.75 (95% CI: 0.70-0.79) for SPE, 2.9 (95% CI: 2.4-3.4) for PLR, 0.36 (95% CI: 0.31-0.42) for NLR, 8 (95% CI: 6-11) for DOR, 0.80 (95% CI: 0.76-0.83) for AUC, and a moderate diagnostic value.
Conclusion:
Our study revealed that blood-circulating ncRNAs could be a moderately effective candidate biomarker for the diagnosis of IS. Furthermore, the combined lncRNAs showed more accurate diagnostic properties than single lncRNAs, and some single miRNAs (e.g., miR-107) showed better diagnostic performance, which may contribute to IS clinical practice.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...